Results 281 to 290 of about 5,533,099 (347)
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Joint profiling of cell morphology and gene expression during in vitro neurodevelopment. [PDF]
Sundaresh A +7 more
europepmc +1 more source
Correction to: Life history and chromosome organization determine chemoreceptor gene expression in rattlesnakes. [PDF]
europepmc +1 more source
Assessment of chemical risk factor for breast cancer based on gene expression profiles. [PDF]
Achebouche R, Taboureau O.
europepmc +1 more source
Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. [PDF]
Newton NM +11 more
europepmc +1 more source
Updated transient gene expression protocol in Expi293F cells using PEI. [PDF]
Hederoth G +7 more
europepmc +1 more source
Sex-Specific Gene Expression Differences in Varicose Veins. [PDF]
Smetanina MA +6 more
europepmc +1 more source
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma. [PDF]
Ramsower CA +19 more
europepmc +1 more source

